Clinical trialNCT05467748RecruitingPhase 1/PHASE2Interventional

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

SponsorVA Office of Research and DevelopmentEnrollment66Non Small Cell Lung Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Daniel S Shin, MD PhD
Michael E. DeBakey VA Medical Center, Houston, TX
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Va Long Beach Healthcare System, Long Beach, Ca
Long Beach, California, United States
Not, yet, recruiting
Va Northern California Health Care System, Mather, Ca
Sacramento, California, United States
Not, yet, recruiting
Va San Diego Healthcare System, San Diego, Ca
San Diego, California, United States
Recruiting
Va Ann Arbor Healthcare System, Ann Arbor, Mi
Ann Arbor, Michigan, United States
Recruiting
Michael E. Debakey Va Medical Center, Houston, Tx
Houston, Texas, United States
Daniel S Shin, MD PhD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 8 Dec 2025
Primary completion: 8 Dec 2027
Completion: 7 Dec 2029
Last update posted: 27 Jan 2026
Registered enrollment: 66
Registry id: NCT05467748

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.